---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-020635"
form_type: "8-K"
ticker: "OSUR"
cik: "0001116463"
company_name: "ORASURE TECHNOLOGIES INC"
filed_at: "2023-05-10T23:59:59+00:00"
generated_at: "2026-06-15T05:49:48.219961+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# OraSure Q1 record revenue $155M, GAAP EPS $0.37; guides Q2 rev $62-67M

## Summary
- Total net revenue $155.0M (+129% YoY); InteliSwab revenue $118.3M (+33% sequential).
- GAAP EPS $0.37, non-GAAP EPS $0.47; cash and short-term investments $112.4M.
- Core business (ex-COVID) revenue $36.6M flat YoY; signed three new molecular partnerships.
- 2Q23 guidance: total revenue $62-67M, InteliSwab $25-30M; cost savings beyond $15M targeted.
- Gross margin 42.5% GAAP, up 200bps sequential; packaging changes expected to save ~$0.50/test.

## SEC filing metadata
- accession: 0000950170-23-020635
- form_type: 8-K
- ticker: OSUR
- cik: 0001116463
- company_name: ORASURE TECHNOLOGIES INC
- filed_at: 2023-05-10T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1116463/000095017023020635/0000950170-23-020635-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1116463/000095017023020635/osur-20230510.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-020635
- JSON: https://secwatch.observer/filing/0000950170-23-020635.json
- Plain text: https://secwatch.observer/filing/0000950170-23-020635.txt

## Key facts
- Earnings Releases
  ORASURE TECHNOLOGIES INC reported three months ended March 31, 2023 results: revenue $ 154,963, net income 27,219, EPS $ 0.37.
  - Period: three months ended March 31, 2023
  - Revenue: $ 154,963
  - Net income: 27,219
  - EPS: $ 0.37
  - Result: reported results
  source text: Three Months Ended March 31, 2023 2022 % Change Core Business $ 36,554 $ 36,675 0 % COVID-19 118,409 31,032 282 Total Net Revenue $ 154,963 $ 67,707 129 % Three Months Ended March 31, 2023 2022 % Change Net revenues $ 154,963 $ 67,707 129 % Gross profit 65,815 24,299 171 Gross margin 42.5 % 35.9 % Non-GAAP gross profit 66,277 25,527 160 Non-GAAP gross margin 42.8 % 37.7 % Operating income (loss) 24,321 (16,172 ) NM Operating margin 15.7 % -23.9 % Non-GAAP operating income (loss) 32,658 (6,584 ) NM Non-GAAP operating income (loss) 21.1 % -9.7 % Net income (loss) 27,219 (19,940 ) NM Non-GAAP net income (loss) 34,454 (10,662 ) NM GAAP EPS $ 0.37 $ (0.28 ) NM Non-GAAP EPS $ 0.47 $ (0.15 ) NM
  evidence_url: https://www.sec.gov/Archives/edgar/data/1116463/000095017023020635/0000950170-23-020635-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.